Time-to-treatment initiation (TTI) in community infusion clinics - decreasing wait times for Canadian oncology patients
By Innomar Strategies
AUTHOR(S): Batist G1, Ghedira S2, Khan A3, Nijjar P4, Sethi SV4, Wehbi H4, Chiasson C4, Drinkwater A4, Anderson S4, Pabla A4, Hopkins J4, Yap B5
1Jewish General Hospital, Montreal, QC, Canada, 2Centre Hospitalier Universitaire Dr-Georges-L.-Dumont, Moncton, NB, Canada, 3University of Calgary, Calgary, AB, Canada, 4Innomar Strategies, Oakville, ON, Canada, 5Innomar Strategies, Toronto, ON, Canada
Ensuring timely access to infusion treatment for oncology patients is important for optimum health outcomes and to reduce feelings of anxiety and distress for both patients and their families.
Innomar Strategies, in collaboration with key opinion leaders from across Canada, developed an analysis demonstrating that private community infusion clinics may have a shorter time to initiate treatment in cancer patients compared to Canadian public healthcare settings. Opportunities exist in Canadian healthcare for the use of both public and private infusion clinics to help improve delays in patient access to cancer infusion treatment.
